Authors:
Ozcan, M
Morton, CT
Solovey, A
Dandelet, L
Bach, RR
Hebbel, RP
Slungaard, A
Key, NS
Citation: M. Ozcan et al., Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantation, THROMB HAEM, 85(2), 2001, pp. 250-255
Authors:
Nath, KA
Grande, JP
Haggard, JJ
Croatt, AJ
Katusic, ZS
Solovey, A
Hebbel, RP
Citation: Ka. Nath et al., Oxidative stress and induction of heme oxygenase-1 in the kidney in sicklecell disease, AM J PATH, 158(3), 2001, pp. 893-903
Authors:
Nath, KA
Shah, V
Haggard, JJ
Croatt, AJ
Smith, LA
Hebbel, RP
Katusic, ZS
Citation: Ka. Nath et al., Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease, AM J P-REG, 279(6), 2000, pp. R1949-R1955
Authors:
Niihara, Y
Shalev, O
Hebbel, RP
Wu, HY
Tu, A
Akiyama, DS
Tanaka, KR
Citation: Y. Niihara et al., Desferrioxamine (DFO) conjugated with starch decreases NAD redox potentialof intact red blood cells (RBC): Evidence for DFO as an extracellular inducer of oxidant stress in RBC, AM J HEMAT, 65(4), 2000, pp. 281-284
Citation: Dk. Kaul et Rp. Hebbel, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice (vol 106, pg 411, 2000), J CLIN INV, 106(5), 2000, pp. 715-715
Citation: Dk. Kaul et Rp. Hebbel, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice, J CLIN INV, 106(3), 2000, pp. 411-420
Citation: Jd. Belcher et al., Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion, BLOOD, 96(7), 2000, pp. 2451-2459
Citation: K. Gupta et al., Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin, BBA-MOL BAS, 1453(1), 1999, pp. 63-73
Authors:
Belcher, JD
Marker, PH
Geiger, P
Girotti, AW
Steinberg, MH
Hebbel, RP
Vercellotti, GM
Citation: Jd. Belcher et al., Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia, J LA CL MED, 133(6), 1999, pp. 605-612
Authors:
De Franceschi, L
Shalev, O
Piga, A
Collell, M
Olivieri, O
Corrocher, R
Hebbel, RP
Brugnara, C
Citation: L. De Franceschi et al., Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity, J LA CL MED, 133(1), 1999, pp. 64-69
Authors:
Gupta, K
Kshirsagar, S
Li, W
Gui, LZ
Ramakrishnan, S
Gupta, P
Law, PY
Hebbel, RP
Citation: K. Gupta et al., VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAP/ERK and SAPK/JNK signaling, EXP CELL RE, 247(2), 1999, pp. 495-504
Authors:
Solovey, A
Gui, LZ
Ramakrishnan, S
Steinberg, MH
Hebbel, RP
Citation: A. Solovey et al., Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: Survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells, BLOOD, 93(11), 1999, pp. 3824-3830